Literature DB >> 22935880

The risks of vascular access.

Peter G Blake, Robert R Quinn, Matthew J Oliver.   

Abstract

Fatal vascular access hemorrhage is considered a rare complication of hemodialysis (HD). Ellingson et al. indicate otherwise, and their data suggest that it causes 0.4-1.6% of deaths in US HD patients. It is more common with grafts than fistulas, and many victims have had previous access hemorrhages. The widespread presumption that a fistula is the best, and a cuffed catheter the worst, access for HD patients needs reassessment, particularly in older, sicker patients.

Entities:  

Mesh:

Year:  2012        PMID: 22935880     DOI: 10.1038/ki.2012.181

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Performance measures in dialysis facilities: what is the goal?

Authors:  Fredric O Finkelstein
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 8.237

2.  Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis.

Authors:  Rasheeda K Hall; Evan R Myers; Sylvia E Rosas; Ann M O'Hare; Cathleen S Colón-Emeric
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

3.  Global Dialysis Perspective: Canada.

Authors:  Peter G Blake
Journal:  Kidney360       Date:  2020-01-16

4.  Longer duration of catheter patency, but similar infection rates with internal jugular vein versus iliac vein tunneled cuffed hemodialysis catheters: a single-center retrospective analysis.

Authors:  Lihua Wang; Fang Wei; Aili Jiang; Haiyan Chen; Guijiang Sun; Xueqing Bi
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

5.  Potentially survivable fatal vascular access hemorrhage with tourniquet use: A post-mortem analysis.

Authors:  Craig Goolsby; Luis E Rojas; Michael Andersen; Nathan Charlton; Laura Tilley; Jason Pasley; Todd E Rasmussen; Matthew J Levy
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.